MET and non-small cell lung carcinoma: Moreover, an acquired sensitive mutation of the c-MET amplification could also be inhibited in patients with non-small cell lung cancers according to a recent piece of literature.[15] Hence, it was implied that c-MET amplification could also be a candidate drive gene in patients with gastric cancer in a particular situation.